We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$5.22B
AUM Growth
Cap. Flow
+$5.1B
Cap. Flow %
97.85%
Top 10 Hldgs %
41.69%
Holding
82
New
81
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.85%
2 Consumer Staples 9.94%
3 Communication Services 9.9%
4 Real Estate 9.59%
5 Energy 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMTH
51
DELISTED
OMTHERA PHARMACEUTICALS INC COM STK (DE)
OMTH
$16M 0.31%
+1,200,000
New +$11.7M
HK
52
DELISTED
Halcon Resources Corporation
HK
$14M 0.27%
+14,354
New +$15.3M
HTSI
53
DELISTED
HARRIS TEETER SUPERMARKETS INC COM STK (NC)
HTSI
$10.6M 0.2%
+225,408
New +$10M
PCO
54
DELISTED
Pendrell Corporation - Class A
PCO
$10.5M 0.2%
+3,997
New +$8.53M
ARB
55
DELISTED
ARBITRON INC (NEW)
ARB
$10.2M 0.2%
+220,000
New +$10.3M
OMX
56
DELISTED
OFFICEMAX INCORPORATED
OMX
$8.8M 0.17%
+860,700
New +$9.96M
PBY
57
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
$8.52M 0.16%
+735,810
New +$8.64M
RPRX
58
DELISTED
Repros Therapeutics Inc.
RPRX
$7.9M 0.15%
+428,000
New +$7.56M
MACK
59
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$7.18M 0.14%
+135,684
New +$5.95M
CIM
60
Chimera Investment
CIM
$1.04B
$6.92M 0.13%
+153,667
New +$7.3M
KMI.WS
61
DELISTED
Kinder Morgan Inc
KMI.WS
$6.81M 0.13%
+1,330,000
New +$7.29M
ICUI icon
62
ICU Medical
ICUI
$4.21B
$5.98M 0.11%
+83,000
New +$5.49M
OREX
63
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5.56M 0.11%
+95,000
New +$5.84M
HZNP
64
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.47M 0.1%
+2,223,071
New +$5.33M
ONXX
65
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
$5.43M 0.1%
+62,500
New +$5.75M
GWPH
66
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.93M 0.09%
+560,000
New +$4.96M
ZTS icon
67
Zoetis
ZTS
$32.4B
$4.7M 0.09%
+152,279
New +$4.93M
TTM
68
DELISTED
Tata Motors Limited
TTM
$4.63M 0.09%
+197,514
New +$5.12M
ANAC
69
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$3.56M 0.07%
+637,500
New +$3.86M
ARQL
70
DELISTED
Arqule Inc
ARQL
$3.4M 0.07%
+1,464,699
New +$3.95M
LPS
71
DELISTED
LENDER PROCESSING SERVICES INC
LPS
$3.38M 0.06%
+104,475
New +$3.04M
STML
72
DELISTED
Stemline Therapeutics, Inc.
STML
$3.22M 0.06%
+135,000
New +$2.15M
GDI
73
DELISTED
GARDNER DENVER,INC
GDI
$2.63M 0.05%
+35,000
New +$2.63M
SVN
74
DELISTED
7 Days Group Holdings Ltd
SVN
$2.62M 0.05%
+190,000
New +$2.59M
GCVRZ
75
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.51M 0.05%
+1,320,000
New +$2.32M

Similar funds

Farallon Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Farallon Capital Management, which disclosed 82 positions worth $5.22B. Its ten largest holdings account for 42% of the portfolio.

Its largest position is NEWS CORPORATION CL-A: 9,255,000 shares worth $302M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, followed by Consumer Staples and Communication Services.

  • Farallon Capital Management's largest Q2 2013 buy was NEWS CORPORATION CL-A: 9,255,000 shares worth $302M.
  • Farallon Capital Management's ten largest holdings make up 42% of its $5.22B portfolio in Q2 2013.
  • Farallon Capital Management disclosed 82 positions in Q2 2013, its first 13F filing on record.

Based on Farallon Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.